How can you find QUATS that fit your requirements? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

How can you find QUATS that fit your requirements?

FeF Chemicals is a Novo Nordisk company that specialises in the supply of ingredients for the pharmaceutical and biopharmaceutical industries, such as and cGMP manufactured Quaternary Ammonium Compounds (usually referred to as Quats) e.g. Benzalkonium Chloride, Cetrimide and Cetrimonium Bromide and Insulin Human for cell culture media.

For our cGMP manufactured Quats we offer:

  • Global regulatory compliance
  • Manufacture in accordance with the highest GMP standards on the market, the ICH Guide Q7 for Active Pharmaceutical Ingredients
  • High purity products
  • Analyses according to multicompendial pharmacopoeias BP, Ph.Eur., USP/NF and JP
  • Regulatory documentation

As an approved supplier by a large number of global leading pharmaceutical companies, FeF Chemicals can assure full traceability and reliability of the raw materials. We have a well-developed management system, allowing tracing where the raw materials are used. We also have close contact with our suppliers and can meet with customer requested specifications. For us, reliability is not just in the system but also in the mindset of our employees.

QUALITY ASSURANCE
Our quality system meets DS/EN ISO 9001 and ICH’s cGMP Guide for Active Pharmaceutical Ingredients (ICH Q7). Uniform quality of finished products is ensured by our efficient quality control systems, computerised materials planning and rigorous laboratory quality control.

CUSTOMIZING QUATS
If the required product is not in the standard assortment, we can design customized products. Our flexible production process can meet customer demands for special chain length distribution and/or solutions of quats mixed in various ratios.

Contact details:
Email: fefinfo@fefchemicals.com
Web: www.fefchemicals.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
FindPharma Custom Search

Click here